Vogelstein B - Search Results

1

Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.

Hempen PM, Zhang L, Bansal RK, Iacobuzio-Donahue CA, Murphy KM, Maitra A, Vogelstein B, Whitehead RH, Markowitz SD, Willson JK, Yeo CJ, Hruban RH, Kern SE. Hempen PM, et al. Among authors: vogelstein b. Cancer Res. 2003 Mar 1;63(5):994-9. Cancer Res. 2003. PMID: 12615714

2

Definition of a consensus binding site for p53.

el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. el-Deiry WS, et al. Among authors: vogelstein b. Nat Genet. 1992 Apr;1(1):45-9. doi: 10.1038/ng0492-45. Nat Genet. 1992. PMID: 1301998

3

The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel.

Mulder JW, Offerhaus GJ, de Feyter EP, Floyd JJ, Kern SE, Vogelstein B, Hamilton SR. Mulder JW, et al. Among authors: vogelstein b. Am J Pathol. 1992 Oct;141(4):797-804. Am J Pathol. 1992. PMID: 1357973 Free PMC article.

4

Genetic alterations in the adenoma--carcinoma sequence.

Cho KR, Vogelstein B. Cho KR, et al. Among authors: vogelstein b. Cancer. 1992 Sep 15;70(6 Suppl):1727-31. doi: 10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p. Cancer. 1992. PMID: 1516027 Review.

5

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM. Fong CT, et al. Among authors: vogelstein b. Cancer Res. 1992 Apr 1;52(7):1780-5. Cancer Res. 1992. PMID: 1551108

6

The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma.

Offerhaus GJ, De Feyter EP, Cornelisse CJ, Tersmette KW, Floyd J, Kern SE, Vogelstein B, Hamilton SR. Offerhaus GJ, et al. Among authors: vogelstein b. Gastroenterology. 1992 May;102(5):1612-9. doi: 10.1016/0016-5085(92)91721-f. Gastroenterology. 1992. PMID: 1568571 Free article.

7

Inherited p53 gene mutations in breast cancer.

Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N. Sidransky D, et al. Among authors: vogelstein b. Cancer Res. 1992 May 15;52(10):2984-6. Cancer Res. 1992. PMID: 1581912

8

Oncogenic forms of p53 inhibit p53-regulated gene expression.

Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Kern SE, et al. Among authors: vogelstein b. Science. 1992 May 8;256(5058):827-30. doi: 10.1126/science.1589764. Science. 1992. PMID: 1589764

9

Mutant p53 proteins bind DNA abnormally in vitro.

Kern SE, Kinzler KW, Baker SJ, Nigro JM, Rotter V, Levine AJ, Friedman P, Prives C, Vogelstein B. Kern SE, et al. Among authors: vogelstein b. Oncogene. 1991 Jan;6(1):131-6. Oncogene. 1991. PMID: 1846954

10

Participation of p53 protein in the cellular response to DNA damage.

Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Kastan MB, et al. Among authors: vogelstein b. Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11. Cancer Res. 1991. PMID: 1933891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

618 results

Search Page